Eton Pharmaceuticals, Inc. (ETON) Net margin 2019–2025
Eton Pharmaceuticals, Inc. (ETON) net profit margin by fiscal year — reported net income divided by reported revenue.
-5.8%FY2025 · since FY2019: -1910.3% → -5.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -5.8% | +4.0 pp |
| FY2024 | -9.8% | -6.8 pp |
| FY2023 | -3.0% | +39.5 pp |
| FY2022 | -42.4% | -33.5 pp |
| FY2021 | -9.0% | +71709.0 pp |
| FY2020 | -71717.9% | -69807.6 pp |
| FY2019 | -1910.3% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice